| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/02/1998 | WO1998013501A2 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales |
| 04/02/1998 | WO1998013500A2 Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines |
| 04/02/1998 | WO1998013499A2 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors |
| 04/02/1998 | WO1998013498A1 Bacillus thuringiensis cryet33 and cryet34 compositions and uses therefor |
| 04/02/1998 | WO1998013497A1 BACILLUS THURINGIENSIS CryET29 COMPOSITIONS TOXIC TO COLEOPTERAN INSECTS AND CTENOCEPHALIDES SPP |
| 04/02/1998 | WO1998013496A1 Chaperone fragments |
| 04/02/1998 | WO1998013495A1 Human rantes mutants incapable of aggregate formation |
| 04/02/1998 | WO1998013494A2 Wilms' tumor wti binding proteins |
| 04/02/1998 | WO1998013493A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 04/02/1998 | WO1998013492A2 Isolation and use of motoneuronotrophic factors |
| 04/02/1998 | WO1998013491A2 Neurogenin |
| 04/02/1998 | WO1998013490A2 A gene related to migraine in man |
| 04/02/1998 | WO1998013489A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 04/02/1998 | WO1998013488A2 Process for the determination of app secretase modulators and the use thereof as agents in the treatment of alzheimer's disease |
| 04/02/1998 | WO1998013486A1 Novel genes associated with enhanced disease resistance in plants |
| 04/02/1998 | WO1998013485A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection |
| 04/02/1998 | WO1998013483A1 Proteases and their variants having peptide protease inhibitors fused to them |
| 04/02/1998 | WO1998013478A2 Antifungal proteins, dna coding therefore, and hosts incorporating same |
| 04/02/1998 | WO1998013476A1 Transgenic model for heart failure |
| 04/02/1998 | WO1998013475A1 Methods for culturing cells |
| 04/02/1998 | WO1998013387A1 Stabilized proteinaceous protease inhibitors and variants thereof |
| 04/02/1998 | WO1998013386A1 Oxygen-binding heme proteins incorporating circularly-permuted globins |
| 04/02/1998 | WO1998013385A2 Non-naturally occurring lipoprotein particle |
| 04/02/1998 | WO1998013384A1 Insulin c-peptides |
| 04/02/1998 | WO1998013383A1 Adenoviral vectors for mutants of human interleukin 6 (hil-6) with hil-6 antagonist activity, pharmaceutical compositions therewith and their uses |
| 04/02/1998 | WO1998013381A1 Modified physiologically active proteins and medicinal compositions containing the same |
| 04/02/1998 | WO1998013380A1 Snrnp sm proteins |
| 04/02/1998 | WO1998013379A1 METHOD OF CELL INHIBITION USING POLYPEPTIDES DERIVED FROM THE VENOM OF THE AUSTRIALIAN JUMPER ANT $i(MYRMECIA PILOSULA) |
| 04/02/1998 | WO1998013378A1 Mannosylated peptides |
| 04/02/1998 | WO1998013377A1 Cytotoxic peptides |
| 04/02/1998 | WO1998013374A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 04/02/1998 | WO1998013071A1 Gene therapy for inhibition of angiogenesis |
| 04/02/1998 | WO1998013060A1 Use of a cytokine regulatory agent to treat rheumatoid arthritis |
| 04/02/1998 | WO1998013059A1 Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells |
| 04/02/1998 | WO1998013058A1 Methods for treating an ischemic disorder and improving stroke outcome |
| 04/02/1998 | WO1998013007A2 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | WO1998012913A1 Expression of globin proteins in plants |
| 04/02/1998 | WO1998012910A2 NOVEL CREBa ISOFORM |
| 04/02/1998 | WO1998007878A3 Long-term expression of gene products by transforming muscle cells |
| 04/02/1998 | WO1998002454A3 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 04/02/1998 | DE19641518A1 Mistletoe chitin-binding lectin |
| 04/02/1998 | DE19641378C1 Diagnosehilfe sowie Verfahren zum Nachweis der Trächtigkeit von Wiederkäuern Diagnostic aid and method for detecting pregnancy in ruminants |
| 04/02/1998 | CA2268265A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection |
| 04/02/1998 | CA2267667A1 Bacillus thuringiensis cryet29 compositions toxic to coleopteran insects and ctenocephalides spp |
| 04/02/1998 | CA2267666A1 Novel morphogen-responsive signal transducer and methods of use thereof |
| 04/02/1998 | CA2267332A1 Methods for culturing cells |
| 04/02/1998 | CA2267221A1 A gene related to migraine in man |
| 04/02/1998 | CA2267179A1 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | CA2267062A1 Diagnostic agent and method to determine pregnancy in ruminants |
| 04/02/1998 | CA2266744A1 Oxygen-binding heme proteins incorporating circularly-permuted globins |
| 04/02/1998 | CA2266626A1 Expression of globin proteins in plants |
| 04/02/1998 | CA2266427A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 04/02/1998 | CA2266422A1 Neurogenin |
| 04/02/1998 | CA2266419A1 Gene therapy for inhibition of angiogenesis |
| 04/02/1998 | CA2266418A1 Proteases and their variants having peptide protease inhibitors fused to them |
| 04/02/1998 | CA2266336A1 Method of cell inhibition using polypeptides derived from the venom of the austrialian jumper ant myrmecia pilosula |
| 04/02/1998 | CA2266329A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 04/02/1998 | CA2266323A1 Stabilized proteinaceous protease inhibitors and variants thereof |
| 04/02/1998 | CA2265554A1 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales |
| 04/02/1998 | CA2264567A1 Antifungal proteins, dna coding therefore, and hosts incorporating same |
| 04/02/1998 | CA2264544A1 Snrnp sm proteins |
| 04/02/1998 | CA2264227A1 Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells |
| 04/02/1998 | CA2263134A1 Cytotoxic peptides |
| 04/02/1998 | CA2236154A1 Novel creba isoform |
| 04/02/1998 | CA2213257A1 Oligopeptide derivatives |
| 04/01/1998 | EP0832981A1 DNA sequences to target proteins to the mammary gland for efficient secretion |
| 04/01/1998 | EP0832979A1 Promoters |
| 04/01/1998 | EP0832978A2 Novel 3-dehydroquinate synthase |
| 04/01/1998 | EP0832977A2 Novel sugar kinase |
| 04/01/1998 | EP0832975A2 Histidinol dehydrogenase from Staphylococcus aureus |
| 04/01/1998 | EP0832973A2 GTP-binding protein |
| 04/01/1998 | EP0832972A2 Cloning, expression and production of tasty peptides |
| 04/01/1998 | EP0832971A1 Adheson variants |
| 04/01/1998 | EP0832901A1 Antibodies to hepatitis G virus, and their diagnostic use to detect HGV, and as therapeutic agent |
| 04/01/1998 | EP0832435A1 Method for the isolation of lipoprotein (a) allowing for the subsequent quantification of its mass and cholesterol content |
| 04/01/1998 | EP0832300A1 Cultured cell line that inducibly expresses the hepatitis b virus genome, and uses thereof for screening antiviral substances |
| 04/01/1998 | EP0832299A1 Use of nucleic acid ligands in flow cytometry |
| 04/01/1998 | EP0832297A1 Methods and compositions for identifying osteogenic agents |
| 04/01/1998 | EP0832295A1 Method for screening for receptor agonists and antagonists |
| 04/01/1998 | EP0832294A1 PCR-BASED cDNA SUBTRACTIVE CLONING METHOD |
| 04/01/1998 | EP0832291A1 Enzyme linked oligonucleotide assays (elonas) |
| 04/01/1998 | EP0832289A1 Novel gene-up regulated in regenerating liver |
| 04/01/1998 | EP0832284A1 Method for the detection of compounds that modulate the effects of the obese protein |
| 04/01/1998 | EP0832282A1 IMPROVED METHOD FOR OBTAINING FULL-LENGTH cDNA SEQUENCES |
| 04/01/1998 | EP0832269A1 Nucleic acid transporters for delivery of nucleic acids into a cell |
| 04/01/1998 | EP0832268A1 A method of expressing and secreting soluble extracellular domains of humain gonadotropin hormone receptors |
| 04/01/1998 | EP0832265A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 04/01/1998 | EP0832261A2 Induction of male sterility in plants by expression of high levels of avidin |
| 04/01/1998 | EP0832260A2 RESISTANCE TO VIRUSES AND VIROIDS IN TRANSGENIC PLANT AND ANIMAL HOSTS EXPRESSING dsRNA-BINDING PROTEIN |
| 04/01/1998 | EP0832256A1 Compositions for expression of proteins in host cells using a preprocollagen signal sequence |
| 04/01/1998 | EP0832253A2 Nucleic acid respiratory syncytial virus vaccines |
| 04/01/1998 | EP0832252A1 Use of gram-positive bacteria to express recombinant proteins |
| 04/01/1998 | EP0832248A2 Expression of functional vertebrate phospholipases in yeast |
| 04/01/1998 | EP0832246A1 Expression of human inducible nitric oxide synthase |
| 04/01/1998 | EP0832243A1 Means for detecting and preventing hiv infection involving use of receptors or binding sites capable of interacting with gp120 |
| 04/01/1998 | EP0832242A1 Neutralizing conformational epitopes of chicken anemia virus |
| 04/01/1998 | EP0832241A1 Mutants of streptococcal toxin a and methods of use |
| 04/01/1998 | EP0832240A1 Cloning and expression of thermostable muts genes and proteins and uses therefor |
| 04/01/1998 | EP0832239A1 Camp factor of streptococcus uberis |
| 04/01/1998 | EP0832238A1 Streptococcal heat shock proteins members of the hsp70 family |